FDA Adverse Event Injury Summary report: N

ON-X MITRAL HEART VALVE WITH CONFORM-X SEWING RING - 25/33

MDR report key: 5995184 · Received October 3, 2016

Report

Report Number
1649833-2016-00023
Event Type
Injury
Date Received
October 3, 2016
Date of Event
June 1, 2016
Report Date
October 3, 2016
Manufacturer
ON-X LIFE TECHNOLOGIES, INC
Product Code
LWQ
UDI-DI
00851788001303
PMA / PMN Number
P000037
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IN 2016, ON-X TECHNOLOGIES INCORPORATED (ON-X) BECAME A WHOLLY OWNED SUBSIDIARY OF CRYOLIFE, INC. (CRYOLIFE). A RETROSPECTIVE REVIEW OF THE ON-X COMPLAINT SYSTEM WAS PERFORMED TO IDENTIFY ANY AREAS REQUIRING ADDITIONAL ACTION AND TO APPROPRIATELY ASSIMILATE THE ON-X PROCESS INTO THE CRYOLIFE QUALITY MANAGEMENT SYSTEM. IN AN ABUNDANCE OF CAUTION, THIS MDR IS BEING REPORTED TO SATISFY REGULATORY REPORTING OBLIGATIONS. THE ON-X 614 HEART VALVE DESIGN FMEA 940816 01 REV S THOROUGHLY IDENTIFIES THE PROCESS AND PRODUCT HAZARDS FOR APPROVED INDICATIONS. EACH INDIVIDUAL HAZARD IS MITIGATED AND REDUCED AS LOW AS POSSIBLE BY DESIGN AND PROCESS. POST PRODUCTION RESIDUAL RISK IS COMMUNICATED IN THE PRODUCT'S LABELING AND INSTRUCTION FOR USE (IFU). REOPERATION IS A KNOWN COMPLICATION OF PROSTHETIC VALVE IMPLANTATION AND IS LISTED IN THE IFU. WITHOUT RETURN OF THE VALVE, A SPECIFIC RISK CANNOT BE IDENTIFIED.

Description of Event or Problem · 1

IMPLANT RECOVERY CARDS RECEIVED INDICATED THAT PATIENT RECEIVED ONXMC-25/33 ((B)(4)) ON (B)(6) 2015 WHICH REQUIRED INTERVENTION/EXPLANT ON (B)(6) 2016 AND REPLACEMENT WITH ANOTHER ONXMC-25/33 FOR UNSPECIFIED REASON. MULTIPLE ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION WERE MADE WITHOUT SUCCESS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
645808 ON-X MITRAL HEART VALVE WITH CONFORM-X SEWING RING - 25/33 MECHANICAL HEART VALVE LWQ ON-X LIFE TECHNOLOGIES, INC ONXMC-25/33 00851788001303

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| O